Smart Pills Technology Market by Technology (Capsule Endoscopy, Patient Monitoring, Drug Delivery) by Disease Indications (Occult GI Bleeding, Crohn’s Disease, Small Bowel Tumors, Celiac Disease) – Business Overview, Analysis and Industry Forecast 201

Global Smart Pills Technology Market was valued at USD 2.62 Billion in the year 2017. Global Smart Pills Technology Market is further estimated to grow at a CAGR of 21% from 2018 to reach USD 8.22 Billion by the year 2023. The smart pill is a wireless capsule that can be swallowed, and with the help of a receiver (worn by patients) and software that analyzes the pictures captured by the smart pill, the physician is effectively able to examine the gastrointestinal tract.

Get Free Access to Sample Report @ https://genesismarketinsights.com/Sample_Request/GENRE224

The global Smart Pills Technology Market is segmented on the basis of technology, disease indication and by region. On the basis of technology, the market is segmented Capsule Endoscopy, Patient Monitoring and Drug Delivery of which Capsule Endoscopy segment is expected to hold the highest market share during the forecast period and are expected to grow with highest CAGR. On the basis of Disease Indications, the market is segmented as Occult GI Bleeding, Crohn’s Disease, Small Bowel Tumors, Celiac Disease, Inherited Polyposis Syndromes and Others in which Occult GI Bleeding segment holds the highest market share in the forecasted period.

North America region holds the highest market share in 2017 and the Asia Pacific is considered as the fastest growing market in the forecasted period. At a country level, the U.S is the major markets in North America region and holds a substantial market share in 2017 and it is projected to grow at a gradual pace in the coming years. North America is anticipated to dominate the market during the analysis period, due to the presence of high-quality healthcare systems and modern medical technology in the country.

GET 40% DISCOUNT ON FINAL REPORT PRICING FOR THE FIRST TIME BUYER @ https://genesismarketinsights.com/viewreport/225/28/Smart-Pills-Technology-Market

Drivers:

• Increasing Preference for Minimally Invasive Device.
• Technological Advancements in Capsule Endoscopes.
• Rise in Incidences of Colon Cancer.

Restraints:

• Technological Incompetence of Capsule Endoscopes.
• Ethical Constraints.

Opportunities:

• Need for Rapid Drug Development Process.

Challenges:

• Potential Health Risks.
• Increasing Cost with Technological Advancement.

Given Imaging Inc. (Israel), Olympus Corporation (Japan), CapsoVision Inc. (U.S), Bio-Images Research Ltd. (U.K), Boston Scientific Corporation (U.S), Ge Healthcare (U.S) and Novartis AG (Switzerland) are some of the key players in the global Smart Pills Technology Market. Rising research and development expenses to address the changing demand of end users. Similarly, growth strategies such as acquisition, merger, and expansion of the distribution network were few techniques adopted by most of the top players in the last 5 years.

Key Benefits for Stakeholders

• Smart Pills Technology product manufacturers
• Healthcare professionals and R&D centers
• Research and Consulting organization
• Government agencies & authorities

By Technology

Capsule Endoscopy

• Small Bowel Video Capsule Endoscopy
• Colon Capsule Endoscopy

Patient Monitoring
Drug Delivery

By Disease Indications

• Occult GI Bleeding
• Crohn’s Disease
• Small Bowel Tumors
• Celiac Disease
• Inherited Polyposis Syndromes
• Others

By Region

• North America
• Europe
• Asia-Pacific
• RoW

Key Market Players

• Given Imaging Inc.
• Olympus Corporation
• Capso Vision Inc.
• Bio-Images Research Ltd.
• Boston Scientific Corporation
• Ge Healthcare
• Acamp
• Novartis AG
• Microchips
• Vitality

(Another brief information of 10 companies will be provided in the report)

Get Full Customized Report @ https://genesismarketinsights.com/Report_Enquiry/GENRE224

About Us:

Genesis Market Insights (GMI), is a subsidiary of Genesis Management & Market Research Pvt.Ltd. (GMMR) having a strong experience both in primary and secondary market research serving small to large scale enterprises across globe. Established in 1993, GMMR has become a recommended brand for Market Research for various international and MNC Corporations with its strong data foundation. With its exhaustive research capabilities, strong analytics services and in house data validation tools, GMMR has delivered actionable, reliable and all-inclusive Market Research Reports. GMMR is growing strongly for last 2 decades with most of the clients providing repeat business for their trust on the data quality and recommendations for decision making.

Contact Us;

Genesis Market Insights (GMI)
902 Broadway, 6th Floor,
New York, NY 10010
(212) 634-4560
Mail us at: info@genesismarketinsights.com
Website: www.genesismarketinsights.com

This release was published on openPR.